Please login to the form below

Cancer Drugs Fund

This page shows the latest Cancer Drugs Fund news and features for those working in and with pharma, biotech and healthcare.

Chi-Med goes for third IPO in Hong Kong

pipeline of cancer drugs through registration trials and regulatory submissions, according an HKEX filing. ... Last August, BeiGene raised a whopping $903m in its HKEX debut, near the top of its target range, to help it fund its own portfolio of cancer

Latest news

NICE nod for Lilly’s breast cancer drug Verzenio via CDF

NICE backed its use via the Cancer Drugs Fund (CDF). ... for-purpose to appraise modern cancer drugs,” she said.
NICE green light for Imfinzi in groundbreaking early lung cancer treatment

NICE has given the green light via the Cancer Drugs Fund (CDF), which means Imfinzi must prove its value further before gaining full recommendation. ... we’ve seen for a number of years in treating locally advanced non-small cell lung cancer.
NICE partially clears Darzalex combo in blood cancer

Approved in second-line use under CDF. NICE has recommended Janssen’s Darzalex in combination with Takeda’s Velcade as a second-line treatment for multiple myeloma via the cancer drugs ... Boysen added: “We have approved daratumumab for use in
How to fix a problem like Orkambi? Solutions suggested ahead of showdown

its cystic fibrosis drugs. ... be seen as a major victory - though this kind of arrangement is currently limited in England to the Cancer Drugs Fund.
Greater Manchester backs move to outcome-based payment

We look forward to working with government, NHS England, industry and patients to make this approach an option for new cancer drugs too.”. ... These include the use of Cancer Drugs Fund ‘managed access scheme’ as well as bespoke outcomes-based

More from news
Approximately 49 fully matching, plus 106 partially matching documents found.

Latest Intelligence

30 Women Leaders in UK Healthcare

A very notable victory has just been announced, with Keytruda becoming the first of the groundbreaking immunotherapy drugs to exit the Cancer Drugs Fund and secure NICE approval for first-line ... Current projects include developing antibodies for use as
Uncertainty, austerity and Brexit

Companies have seen repeated attempts by the Government and NHS England to prevent patients from accessing new medicines, from the controversial reforms to the Cancer Drugs Fund to the ‘run rate’
Opening up market access

In this PME market access supplement we look at the direction of travel in France and Germany and there’s an introduction to the UK’s new-look Cancer Drugs Fund.
Stepping up to payer-driven market access

products. In the UK, for instance, NICE now regulates access to the Cancer Drugs Fund, and products will need to meet NICE thresholds in order to be reimbursed.
The price is right?

Health stakeholders should focus not on the cost of drugs but on the value they provide. ... Proposed changes to the Cancer Drugs Fund in England include provision for access at a provisional price that is considered potentially cost-effective.

More from intelligence
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest appointments

New health ministers and re-appointments after reshuffle

Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around ... the uptake of new drugs and med tech, and the
Celgene names general manager for UK and Ireland

This is even more pertinent with the recent changes to the Cancer Drugs Fund, which I strongly hope will enable patients with myeloma and metastatic pancreatic cancer to continue to be

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

How to make the most of online communities

topical healthcare issues including NICE, the Cancer Drugs Fund, biosimilars, the impact of Digital on pharma and the NHS in general.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!: EXCELLENT DAY RATES AVAILABLE

Account Director, Medical Education: Salary TBC

Director – Healthcare PR: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer: Competitive salary and benefits

PR Associate Director – Consumer Health & Beauty: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...